Hinge Health (HNGE) Cost of Revenue (2024 - 2026)

Hinge Health has disclosed Cost of Revenue across 3 years of filings, most recently posting $28.1 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $28.1 million, up 19.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $427.3 million (up 284.94% YoY), and the FY2025 annual result was $317.0 million, up 250.21% from the prior year.
• Cost of Revenue came in at $28.1 million for Q1 2026 at Hinge Health, down from $224.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $224.0 million in Q4 2025 to a low of $21.2 million in Q4 2024.
• The 3-year median for Cost of Revenue is $28.0 million (2025), against an average of $67.3 million.
• Across the five-year window, Cost of Revenue jumped 958.26% in 2025 and increased 19.0% in 2026, its largest moves.
• Hinge Health's Cost of Revenue stood at $21.2 million in 2024, then surged by 958.26% to $224.0 million in 2025, then sank by 87.47% to $28.1 million in 2026.
• The last three Cost of Revenue figures came in at $28.1 million (Q1 2026), $224.0 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.